The biopsy results you posted would indicate that those immunohistochemical tumor markers were "negative" and thus adding to the clinical data which supports continued active surveillance.

Here's a link to the use of MRIs vs TRUS biopsies if you and your medical team decide on active surveillance - https://www.urotoday.com/video-lectures/localized-prostate-cancer/video/mediaitem/2925-using-mri-to-safely-prevent-unnecessary-protocol-advised-repeat-biopsy-during-active-surveillance-journal-club-christopher-wallis-zachary-klaassen.html?utm_source=newsletter_11193&utm_medium=email&utm_campaign=expert-review-journal-clubs-in-the-management-of-localized-prostate-cancer

Again, discuss with your medical team.

Kevin